Skip to main content
Clinical Trials/IRCT20200707048045N1
IRCT20200707048045N1
Completed
Phase 2

Hemodynamic changes (heart rate, blood pressure and oxygen saturation) comparing mepivacaine Hcl 3% with perilocaine 3%+ felypressin in controlled hypertensive patients after infra-alveolar block.

Shiraz University of Medical Sciences0 sites32 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
Shiraz University of Medical Sciences
Enrollment
32
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
5 years ago
Study Type
Interventional
Sex
All

Investigators

Eligibility Criteria

Inclusion Criteria

  • Patients with controlled hypertension who are willing to cooperate

Exclusion Criteria

  • Patients with a history of drug allergy, a history of asthma, nasal polyps, bronchospasm or angioedema,
  • heart failure or liver failure,
  • patients with idiopathic or congenital methemoglobinemia,
  • patients with bleeding disorders,
  • patients taking anticoagulant drugs
  • failure to sign a written consent

Outcomes

Primary Outcomes

Not specified

Similar Trials